Systematic (IUPAC) name | |
---|---|
3-allyl-6-bromo-1-phenyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol | |
Clinical data | |
Pregnancy cat. | ? |
Legal status | ? |
Identifiers | |
CAS number | 135974-57-1 |
ATC code | ? |
PubChem | CID 11957483 |
ChemSpider | 8627436 |
ChEMBL | CHEMBL34095 |
Chemical data | |
Formula | C19H20BrNO2 |
Mol. mass | 374.27 g/mol |
SMILES | eMolecules & PubChem |
|
|
(verify) |
(what is this?)
6-Br-APB is a synthetic compound that acts as a selective D1 agonist,[1] with the (R)-enantiomer being a potent full agonist, while the (S) enantiomer retains its D1 selectivity but is a weak partial agonist.[2] (R)-6-Br-APB and similar D1-selective full agonists like SKF-81,297 and SKF-82,958 produce characteristic anorectic effects, stereotyped behaviour and self-administration in animals, with a similar but not identical profile to that of dopaminergic stimulants such as amphetamine.[3][4][5]
|
|